Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment

IntroductionMethimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficient...

Полное описание

Библиографические подробности
Главные авторы: Daniela Gallo, Antonino Bruno, Matteo Gallazzi, Simona Antonia Maria Cattaneo, Giovanni Veronesi, Angelo Genoni, Maria Laura Tanda, Luigi Bartalena, Alberto Passi, Eliana Piantanida, Lorenzo Mortara
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2023-04-01
Серии:Frontiers in Endocrinology
Предметы:
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fendo.2023.1145811/full